جست‌وجوی استاد و پژوهشگر

Wolfgang Wüsterمشاهده پروفایل

استاد

• Evolutionary Biology
• Snake Systematics
• Venom Toxicology
• +۵ مورد دیگر

Professor Wolfgang Wüster is a Professor in Zoology (Molecular Ecology) at Bangor University's School of Environmental and Natural Sciences. His research focuses on evolutionary biology, snake systematics, and venom toxicology, using snakes as model systems. He teaches courses in zoology and herpetology, including Arizona fieldwork and advanced herpetology modules. Education: PhD in Systematics of Asian cobras from the University of Aberdeen (1990). His research interests include the evolution of venom composition, species delimitation in snake complexes, warning signals, biogeography, and conservation genomics. He supervises postgraduate students in topics like European viper conservation and snake systematics. Recent publications highlight his work on snake venoms, taxonomy, and the impacts of climate change on reptile species. He collaborates globally, contributing to antivenom efficacy studies and venom evolution research. Professor Wüster has been involved in projects such as genomic studies of adders and the phylogeography of vipers. His work bridges molecular ecology with conservation, emphasizing practical applications in biodiversity preservation.

• Mechanobiology
• Biomechanics
• Organ-on-chip
• +۵ مورد دیگر

Associate Professor Arnold Lining Ju is a biomedical engineer at the University of Sydney's School of Biomedical Engineering, affiliated with multiple institutes including the Heart Research Institute and Sydney Nano Institute. He holds academic positions in both the Faculty of Engineering and Faculty of Medicine & Health. Education: BSc from Peking University, PhD from Georgia Tech and Emory University (USA). Honors include Snow Fellowship, Heart Foundation Future Leader Fellowship, and multiple awards for cardiovascular research innovation. Research focuses on mechanobiology and biomechanics of thrombosis, developing microfluidic devices and organ-on-chip systems. Key projects include AI-driven single-cell nanotools, 3D biofabrication, and anti-thrombotic peptide design. Leads interdisciplinary teams and collaborates internationally with institutions like Harvard and University of Texas. Teaching roles include coordinating advanced cellular biomechanics courses and supervising PhD/Masters students in biomedical engineering and physiology. Over 50 peer-reviewed publications, with contributions to Nature Materials, Nature Communications, and other top journals.

• Vascular Medicine
• Haemostasis
• Thrombosis
• +۳ مورد دیگر

Gordon Lowe is an Honorary Senior Research Fellow at the University of Glasgow's School of Cardiovascular & Metabolic Health. He holds a DSc from Glasgow University (2006) and has been recognized with prestigious awards, including the Kettle Lecture (2006) and the Investigator Award from the International Society of Thrombosis and Haemostasis (2009). His research focuses on vascular diseases (coronary heart disease, stroke, peripheral arterial disease, venous thrombosis) and haemostasis, particularly in relation to haemophilia. He led the Haemostasis and Thrombosis Research Laboratory from 1987, contributing to clinical trials and epidemiological studies on thrombotic and haemorheological factors. Education: MB, ChB (with Honours and gold medal) from the University of St. Andrews (1972). Postgraduate training in internal and vascular medicine at Dundee, Nottingham, and Glasgow. Career highlights include serving as Professor of Vascular Medicine at Glasgow University (1993–2009) and continuing as an Emeritus Professor. Research interests include the interplay between haemostatic factors and cardiovascular outcomes, with over 550 refereed publications. He chairs editorial boards for journals like Journal of Thrombosis and Haemostasis and contributes to clinical guidelines through the Scottish Intercollegiate Guidelines Network (SIGN). Professional roles include past presidency of the British Society for Haemostasis and Thrombosis, and active participation in clinical trial committees. Scientific contributions span meta-analyses of coagulation factors, epidemiological studies on VTE risk, and historical analyses of thrombosis. He is affiliated with the Diabetes, Renal, Endocrine, and Metabolic Medicine Research Theme within his school.

• Epidemiology of Birth Defects
• Gene-Environment Interactions in Perinatal Health
• Nutrition and Reproductive Outcomes
• +۴ مورد دیگر

Gary M. Shaw is the Rosemarie Hess Professor and Professor (Research) at Stanford University , with courtesy appointments in the Department of Epidemiology and Population Health and Department of Obstetrics & Gynecology - Maternal Fetal Medicine . He serves as Co-PI of the March of Dimes Prematurity Research Center at Stanford and PI of the California Center for Finding Causes and Preventives of Birth Defects . His research focuses on the Epidemiology of birth defects Gene-environment interactions in perinatal outcomes Nutritional factors in reproductive health . He has developed machine learning approaches for precision parenteral nutrition and predictive models for preterm birth, while investigating persistent metabolomic signatures following hypertensive pregnancy disorders. Shaw's recent work explores Climate change impacts on reproductive health Maternal-fetal immune interactions Epigenetic mechanisms in perinatal disease with applications of multiomics to neonatal intensive care units. As a member of Bio-X and the Maternal & Child Health Research Institute , he contributes to translational research networks while serving as Associate Editor for Birth Defects Research and American Journal of Medical Genetics . He supervises Med Scholar Project student Richard Liang Doctoral co-advisor for Saskia Comess and Richard Liang Master's advisor for Lenae Joe while leading the Division of Neonatology as Associate Chair for Clinical Research (2012-2025). His laboratory work integrates Metabolomic profiling Proteomic analysis Computational modeling Machine learning for biomedical data to advance neonatal care through precision medicine approaches.

Antti Posoمشاهده پروفایل

استاد

• Drug Design
• Molecular Modeling
• Anti-Cancer Drugs
• +۳ مورد دیگر

Antti Poso is a Professor of Drug Design at the University of Eastern Finland (Kuopio), affiliated with the School of Pharmacy under the Faculty of Health Sciences. His research focuses on computer-aided molecular design, particularly targeting anti-cancer drugs and anti-microbials. Key projects include the EDCMET project (2019–2024) and the GeneCellNano Flagship (2020–2028). He leads the Molecular Modeling and Drug Design Research Group, specializing in QSAR analysis, kinase inhibition profiling, and systems-level drug response modeling. Recent work includes studies on SARS-CoV-2 inhibitors, endocrine disruptors, and bacterial pathogenesis. His findings bridge chemical structure with biological outcomes, leveraging computational tools like CCA and molecular dynamics simulations. Collaborations span medicinal chemistry, pharmacology, and systems biology, contributing to both academic and applied drug discovery efforts. Education: Not explicitly stated in texts; assumed to hold advanced degrees in pharmacy or chemistry. Research Themes: Drug design, molecular modeling, QSAR, computational biology, and anti-infective agents. Key Contributions: Over 150+ publications, including influential works on chemoinformatics-driven drug response analysis and structure-based inhibitor design. Publications highlight advancements in kinase inhibitors, anti-microbial strategies, and viral hijacking mechanisms. His work emphasizes translating computational insights into therapeutic solutions for cancer, infectious diseases, and metabolic disorders.

• Medical Physiology
• Oxidative Stress and Inflammation
• Medical Education Research
• +۲ مورد دیگر

Suzanne Estaphan is a Senior Lecturer in Medical Science (Physiology and Clinical Pharmacology) at the Australian National University (ANU) School of Medicine and Psychology . She holds qualifications including a Doctorate of Physiology (2015) , MSc in Physiology (2012) , MBBCh (2005) , and Basic Certificate in Medical Education (2018) . Her academic roles span curriculum development, admissions, and assessment committees in the ANU Medical School. Senior Lecturer, ANU (2023–present) Academic Editor, PLOS ONE (2024–present) Review Editor, Frontiers in Physiology (2023–present) Dr. Estaphan's research bridges oxidative stress and inflammation in disease pathology with medical education innovation . Her work explores antioxidant interventions for organ damage and investigates AI/virtual reality applications in education. Recent projects include studying sleep dysfunction in eating disorders and diabetes medication effects on exercise capacity . Between 2023–2025, her 15 most recent publications span oxidative stress , medical education , and molecular pathophysiology . Themes include homeostasis , clinical reasoning , and metabolic disorders , with subfields like MMP-9 biology , pancreatic injury , and VR-based hypoxia training . Scientific accolades include the American Physiological Society Travel Award (2017) and recognition as Senior Fellow of the Higher Education Academy (2023) . She mentors medical students, contributes to national physiology curriculum consensus projects, and has secured approximately $200,000 in research funding .

• Critical Care Medicine
• Immunology
• Trauma Surgery
• +۵ مورد دیگر

Vanessa Nomellini, MD, PhD is an Associate Professor in the Division of Burn, Trauma, Acute and Critical Care Surgery at UT Southwestern Medical Center. She joined UT Southwestern in 2023 as the director of research for her division and leader in the Critical Care Outcomes Research Translation (CORT) group. Education: Dr. Nomellini earned her MD and PhD in Cellular and Molecular Biochemistry from Loyola University. She completed her general surgery residency at the University of Wisconsin and Surgical Critical Care fellowship at the University of Pennsylvania. Research Interests: Her work focuses on immune dysfunction in critically ill patients, particularly sepsis and trauma-induced immunosuppression. She leads studies on immune recovery mechanisms and develops the ICU Recovery Program for long-term patient management. Her NIH-funded research (R35 NIGMS) investigates immune suppression through both animal models and human observational studies. Publications Trends: Her recent work emphasizes sepsis pathophysiology, coagulopathy management, and clinical improvements in critical care. Key areas include immunomodulatory therapies, biomarker utility, and optimizing ICU protocols. Scientific Awards: Recipient of NIGMS R35 grant (2019-current) Advising & Grants: Leads a multi-institutional research team and holds leadership roles in CORT. Her grants focus on translational immunology and critical care outcomes. Labs & Teams: Directs research at UT Southwestern's Critical Care Division, collaborating with Drs. Levi and Carlson in CORT initiatives.

Helen Suhمشاهده پروفایل

استاد

• Environmental Health
• Environmental Epidemiology
• Air Pollution
• +۲ مورد دیگر

Helen Suh is a Professor at Tufts University, jointly appointed in the departments of Civil and Environmental Engineering and Community Health . As an internationally-recognized expert in air pollution health effects, she combines environmental epidemiology , exposure science , and data analytics to investigate how pollutants impact human health. Sc.D. , Harvard University (1993) M.S. , Harvard University (1990) S.B. , Massachusetts Institute of Technology (1985) Her research focuses on three areas: air pollutant impacts on cognitive performance and child development , multi-pollutant health effects , and GIS-based spatio-temporal modeling for epidemiological studies. Recent publications highlight her work on PM2.5 measurement error correction , hormonal disruptions in pregnancy , and machine learning applications in environmental health analysis. Current trends include: Advanced statistical methods for exposure assessment Multi-omics approaches to cardiometabolic health International comparative studies (e.g., Tehran, Puerto Rico) Long-term mortality analysis in Medicare populations Pollution-immune system interactions in vulnerable groups Policy-relevant modeling for air quality standards Helen Suh has served as an Associate Editor for the Journal of Exposure Science and Environmental Epidemiology and advised major U.S. and international health organizations. Her work spans over 150 publications and integrates multidisciplinary team leadership in environmental health science. Her laboratory develops large-scale data analytics tools and spatio-temporal exposure models to support population-level health research. Current projects include air pollution and aging cohorts , urban environmental noise measurement , and epigenetic responses to pollutants .

• Autism Spectrum Disorder
• Biostatistical Methods
• Chronic disease
• +۴ مورد دیگر

Xiaoyu Che is an Assistant Professor of Biostatistics at Columbia University's Mailman School of Public Health, where he serves as the principal biostatistician in the Center for Infection and Immunity (CII) at Columbia University Irving Medical Center. His work bridges statistical methodology with biomedical research, focusing on complex disease mechanisms through advanced data analysis approaches. Dr. Che received his academic training at prestigious institutions: BS in Mathematics from Zhejiang University (2006) PhD in Mathematics from Claremont Graduate University (2013) Dr. Che's research program centers on the development and application of statistical methods for multi-omics analyses, with particular focus on understanding the pathogenesis of chronic and neurodevelopmental conditions. His work spans multiple domains including Autism Spectrum Disorder (ASD), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and Gulf War Illness (GWI). He employs sophisticated biostatistical approaches to integrate diverse biological data types, revealing novel insights into disease mechanisms. His methodological expertise includes Bayesian statistics, metabolomic analysis, immune signature identification, and microbiome characterization, all aimed at translating complex biological data into meaningful clinical insights. Analysis of Dr. Che's publication record reveals a strong thematic focus on applying advanced statistical methods to understand complex disease mechanisms. His work consistently bridges biostatistical innovation with biomedical discovery, particularly in the areas of neurodevelopmental disorders and chronic fatigue conditions. The publications demonstrate progression from foundational methodological work to increasingly sophisticated multi-omics integration approaches, reflecting both technical growth and expanding research impact. His collaborative approach is evident through numerous high-impact publications with interdisciplinary teams across Columbia University and beyond. Dr. Che teaches BIST P8104: Probability in the Biostatistics MS degree program at Columbia, demonstrating his commitment to training the next generation of biostatisticians. While specific grant information isn't detailed in the provided materials, his extensive publication record across multiple high-impact journals suggests successful grant funding supporting his research program. As principal biostatistician in the Center for Infection and Immunity, Dr. Che plays a critical role in the analytical framework of the center's research initiatives. His work supports the center's mission to understand the relationship between infectious agents and human health through rigorous quantitative analysis. The collaborative nature of his research is evident in the diverse range of co-authors spanning immunology, virology, microbiology, and clinical medicine.

Stuart Allanمشاهده پروفایل

استاد

• Neuroinflammation
• Stroke Pathology
• Cytokine Signaling
• +۳ مورد دیگر

Stuart Allan is Professor of Neuroscience at the University of Manchester's Faculty of Life Sciences, Division of Neuroscience. His research focuses on neuroinflammation mechanisms in stroke and neurodegenerative diseases, with particular expertise in cytokine signaling (especially IL-1) and neuronal injury pathways. He leads projects targeting interleukin-1 for acute brain injury treatment and investigates stroke-immune mediated pathways in cognitive trajectory. Research Interests: Neuroinflammatory responses, cytokine-mediated neuronal injury, stroke pathophysiology, Alzheimer's disease mechanisms, and neurovascular coupling. His work bridges experimental paradigms (in vitro and in vivo) with clinical applications. Education: PhD Biomedical Sciences (University of Aberdeen, 1990-1993) BSc Pharmacology (University of Dundee, 1986-1990) Professional Appointments: Professor of Neuroscience (2012-present) Senior Lecturer (2008-2012) Lecturer (2002-2008) Postdoctoral Research Associate (1993-2002) Research Beacons & Institutes: Dementia@Manchester, Manchester Regenerative Medicine Network, Lydia Becker Institute, Christabel Pankhurst Institute, Manchester Institute for Collaborative Research on Ageing. Scientific Output: 179 research outputs including articles on cerebrovascular health, neurovascular coupling, and cytokine mechanisms in stroke models. Research demonstrates consistent focus on translational neuroscience and neuroinflammatory pathways.

Toni M. Antalisمشاهده پروفایل

استاد

• Vascular Biology
• Ovarian Cancer
• Inflammation
• +۶ مورد دیگر

Toni M. Antalis, PhD, is a Professor in the Department of Pharmacology & Physiology at the University of Maryland School of Medicine. She serves as Associate Director of Training and Education for the Marlene and Stewart Greenebaum Comprehensive Cancer Center and Director of the Program in Molecular Medicine. Her research bridges vascular biology and cancer, focusing on membrane-anchored serine proteases and their role in tumor metastasis, inflammation, and coagulation. Doctorate in Biochemistry from Rice University Postdoctoral training in Cell Biology at Baylor College of Medicine Her laboratory investigates how protease-activated receptors (PARs) and the plasminogen activation system influence vascular disease and ovarian cancer progression. Current projects include studying fibrinolysis in thrombus resolution and developing protease-targeted therapies for metastatic ovarian cancer. Recent publications highlight roles of matriptase, testisin, and PAI-2 in tumor dissemination and vascular permeability. Dr. Antalis' research is funded by the National Institutes of Health (NIH), the Department of Defense, and a VA Merit Award. She has previously received support from the Lance Armstrong Foundation and Rivkin Center. She co-directs NIH-funded T32 and PREP programs for cancer training. Mentored numerous PhD students and postdoctoral fellows Developed engineered anthrax toxin prodrugs for ovarian cancer therapy (patents 10,568,929 and 11,013,784)

Craig Morrellمشاهده پروفایل

استاد

• Platelet Biology
• Vascular Inflammation
• Thrombosis
• +۵ مورد دیگر

Craig Morrell is a Professor at the University of Rochester School of Medicine and Dentistry , with joint appointments in the Departments of Medicine , Microbiology and Immunology , and Pathology and Laboratory Medicine . He serves as Associate Director of the Aab Cardiovascular Research Institute . Education: Sc.B. in Biology, Brown University (1995) D.V.M. , Tufts University School of Veterinary Medicine (2000) Ph.D. in Pathobiology, Johns Hopkins University (2005) His research examines the interface between platelets, vascular biology, and immune cells , focusing on platelet roles in thrombosis, inflammation, and immune regulation. Using advanced mouse models , his lab investigates platelet-derived mediators like β2M and PF4 in diseases such as malaria, stroke, and myocardial infarction. Article trends highlight platelets' dual roles in thrombosis and immune modulation , with recurring themes in vascular inflammation , ERK5 signaling , and age-related immune dysfunction . Scientific Awards: Kenneth M. Brinkous Young Investigators Prize (2008) Deans Gift research award (2006) Multiple travel scholarships and fellowships (2003-2005) Pathology Award-Excellence in Pathology (2000) Mentoring and Teaching : He has mentored 8 doctoral students , 7 undergraduates , and 6 postdoctoral fellows , with a focus on diversity. He serves on thesis committees and the URMC MSTP (MD/PhD) admissions committee . Labs and Collaborations : Leads the Morrell Lab at the Aab Cardiovascular Research Institute, collaborating with institutions like Johns Hopkins and Medical College of Wisconsin.

• Chemical Engineering
• Biorefineries
• Pulp & Paper Processing
• +۷ مورد دیگر

Bandaru Ramarao is a Professor and Chair of the Department of Chemical Engineering at the SUNY College of Environmental Science & Forestry (ESF). He holds a Ph.D. in Chemical Engineering from Clarkson University and has over three decades of academic and research experience. His expertise spans separation processes, biorefinery technologies, pulp and paper engineering, and environmental biotechnology. He has authored numerous books and journal papers, including Granular Filtration of Aerosols and Hydrosols and Separation Processes in Biorefineries . Education: Ph.D. (1986), M.S. (1982), and B.S. (1980) in Chemical Engineering from Clarkson University and the University of Madras, respectively. Research Interests: Focus on sustainable biorefineries, PFAS removal using nanomaterials, enzymatic hydrolysis of lignocellulosic biomass, and advanced filtration technologies. His work bridges fundamental engineering principles with industrial applications, particularly in the pulp and paper sector. Publications: Over 100 peer-reviewed articles and patents, including innovations in flocculation, biopolymer production, and geotextile dewatering. Recent work explores PFAS removal via cellulose nanocrystals and bioplastic synthesis from waste streams. Awards: Recipient of the Andrew Chase Award (2014) and the Alkyl Amines Tilak ChemCon Award (2012). Recognized for contributions to forest bioproducts and sustainable engineering. Advising & Grants: Supervises graduate students in MS and PhD programs, focusing on bioprocess engineering and paper physics. Leads research projects funded by NASA, industry partnerships, and academic grants. Labs & Teams: Director of the Empire State Paper Research Institute, advancing innovations in papermaking and biorefinery processes. Collaborates with global institutions on filtration, biorefinery design, and environmental remediation.

Ai-ris Yonekura Collierمشاهده پروفایل

استادیار

• Maternal-Fetal Medicine
• Immunology in Pregnancy
• Infectious Diseases in Pregnancy
• +۳ مورد دیگر

Dr. Ai-ris Yonekura Collier serves as Assistant Professor in Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School and Staff Physician in the Department of Obstetrics and Gynecology at Beth Israel Deaconess Medical Center (BIDMC). She concurrently holds a Physician-Scientist position at BIDMC's Center for Virology and Vaccine Research (CVVR) and co-directs the Clinical Trials Unit within CVVR, establishing a critical bridge between maternal-fetal medicine and virology research. Her academic foundation includes: B.S. in Biology (Minor: Chemistry) from Massachusetts Institute of Technology (2005) M.D. from Harvard Medical School through Harvard-MIT Health Sciences & Technology Program (2011) Obstetrics & Gynecology Residency at UCLA (2011-2015) Maternal-Fetal Medicine Fellowship at BIDMC (2015-2018) Dr. Collier's research centers on maternal immune tolerance mechanisms in placental development, with dual investigative tracks: (1) Characterizing cellular immune phenotypes in pregnancy disorders like preeclampsia and fetal growth restriction, and (2) Analyzing infectious disease impacts including Zika virus and SARS-CoV-2. Her translational approach integrates longitudinal biospecimen repositories with clinical observations, emphasizing the inclusion of pregnant populations in vaccine trials. As an educator, she actively mentors trainees and advocates for policy changes in clinical trial design. Recent publications demonstrate a pronounced focus on viral immunology during the pandemic era, with 7 of 9 recent papers addressing SARS-CoV-2 variants, vaccine responses, and Mpox immunity. These works reveal consistent methodological themes: neutralization assays against emerging variants, analysis of coagulation-inflammation pathways in vaccine complications, and sensitive diagnostic approaches for prior infections. Concurrently, she maintains her foundational research in placental immunology, exemplified by cytokine studies in preeclampsia. Her scientific recognition includes: NIH Loan Repayment Program (2018-2020) Mentor Award from ACOG District I (2021) Translational Research Hubs Spark Grant Award (2022) Rookie of the Year Award at BIDMC (2016) Multiple research presentation awards from perinatal societies As Principal Investigator of the Yonekura Collier Laboratory and Co-Director of the Clinical Trials Unit, she manages substantial grant funding including NIH/NICHD support and institutional translational grants. Her leadership extends to hospital-wide initiatives like the BIDMC COVID-19 Biorepository, while her advocacy focuses on rectifying historical exclusions of pregnant individuals from clinical research. She maintains active collaborations across Harvard's immunology and virology departments. The Yonekura Collier Laboratory operates within CVVR's collaborative ecosystem, integrating with Dan Barouch's research group and the broader Harvard Medical School community. Her team combines clinical obstetric expertise with advanced immunological techniques to investigate fetal-maternal interface biology, creating a unique interdisciplinary hub for perinatal infectious disease research.

Thomas Papمشاهده پروفایل

استاد

• Rheumatology
• Inflammation
• Arthritis
• +۴ مورد دیگر

Thomas Pap serves as Professor at the Department of Molecular Medicine within the Institute of Musculoskeletal Medicine (IMM) at the University of Muenster. He actively participates in the "Cells in Motion" research cluster and the Imaging Network, focusing on cell dynamics and imaging applications in musculoskeletal pathologies. His research centers on molecular mechanisms of inflammatory joint diseases, with key emphases on: Destructive arthritis pathogenesis through fibroblast transformation and adherens junction dynamics Regulation of alarmin activity (S100A8/S100A9) in sterile inflammation TRP channel modulation of osteoclast function and bone loss Translational models for tendon healing and microsurgical reconstruction Advanced imaging techniques for monitoring inflammatory lesions Analysis of his 2013-2021 publications reveals consistent interdisciplinary work bridging immunology, cell biology, and clinical applications. His studies frequently employ molecular imaging and translational models to investigate rheumatoid arthritis mechanisms, neutrophil chemotaxis, and bacterial immune evasion, with strong emphasis on therapeutic targeting of inflammatory pathways. The Pap Group operates within the Multiscale Imaging Centre (MIC), collaborating on pilot projects and the "Train Gain Fellowships" graduate program. Their work integrates with the university's broader Imaging Network, utilizing advanced microscopy and molecular techniques to study cell dynamics in inflammatory conditions.